Morio T, Nonoyama S, Yata J
Clin Exp Immunol. 1989; 78(2):159-65.
PMID: 12412742
PMC: 1534661.
Siziopikou K, Ahn M, Casey L, Silver M, Harris J, Braun D
Cancer Immunol Immunother. 1997; 45(1):29-36.
PMID: 9353424
PMC: 11037803.
DOI: 10.1007/s002620050397.
Rosati E, Scaringi L, Cornacchione P, Fettucciari K, Sabatini R, Mezzasoma L
Immunology. 1996; 89(1):142-51.
PMID: 8911152
PMC: 1456665.
DOI: 10.1046/j.1365-2567.1996.d01-702.x.
Saklatvala J, Pilsworth L, Sarsfield S, Gavrilovic J, Heath J
Biochem J. 1984; 224(2):461-6.
PMID: 6097218
PMC: 1144453.
DOI: 10.1042/bj2240461.
Allavena P, Scala G, Djeu J, Procopio A, Oppenheim J, Herberman R
Cancer Immunol Immunother. 1985; 19(2):121-6.
PMID: 3921231
PMC: 11039260.
DOI: 10.1007/BF00199719.
Natural killer activity of lymphocytic infiltrates in mouse mammary lesions.
Wei W, Heppner G
Br J Cancer. 1987; 55(6):589-94.
PMID: 3620299
PMC: 2002039.
DOI: 10.1038/bjc.1987.120.
Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells.
Bender J, Pardi R, KARASEK M, Engleman E
J Clin Invest. 1987; 79(6):1679-88.
PMID: 3495552
PMC: 424501.
DOI: 10.1172/JCI113007.
Complete nucleotide sequence of the gene for human interleukin 1 alpha.
Furutani Y, Notake M, Fukui T, Ohue M, Nomura H, Yamada M
Nucleic Acids Res. 1986; 14(8):3167-79.
PMID: 3486405
PMC: 339740.
DOI: 10.1093/nar/14.8.3167.
Lesional modulation of peripheral monocyte leucotactic responsiveness in leprosy.
Campbell P, Tolson T, Yoder L, LOESCH J, Krahenbuhl J
Clin Exp Immunol. 1987; 70(2):289-97.
PMID: 3427823
PMC: 1542101.
A macrophage-monocyte cell line from a dog with malignant histiocytosis.
Wellman M, Krakowka S, Jacobs R, Kociba G
In Vitro Cell Dev Biol. 1988; 24(3):223-9.
PMID: 3350786
DOI: 10.1007/BF02623551.
Human natural killer (NK) cells produce a late-acting B-cell differentiation activity.
Kimata H, Sherr E, Saxon A
J Clin Immunol. 1988; 8(5):381-9.
PMID: 3263382
DOI: 10.1007/BF00917154.
Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.
Malavasi F, Tetta C, Funaro A, Bellone G, Ferrero E, Franzone A
Proc Natl Acad Sci U S A. 1986; 83(8):2443-7.
PMID: 3085094
PMC: 323314.
DOI: 10.1073/pnas.83.8.2443.
Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populations.
Pistoia V, Carroll A, Prasthofer E, Tilden A, Zuckerman K, Ferrarini M
J Clin Immunol. 1986; 6(6):457-66.
PMID: 3023432
DOI: 10.1007/BF00915251.
The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma.
Herman J, Kew M, Rabson A
Cancer Immunol Immunother. 1986; 21(1):26-30.
PMID: 3002605
PMC: 11038459.
DOI: 10.1007/BF00199373.
Defective interleukin-1 production by natural killer cells of patients with cancer.
Herman J, Kew M, Rabson A
Cancer Immunol Immunother. 1985; 19(2):148-53.
PMID: 2985238
PMC: 11039131.
DOI: 10.1007/BF00199724.
Helper activity by human large granular lymphocytes in in vitro immunoglobulin synthesis.
Rodriguez M, Blanca I, Baroja M, Arama S, Leon-Ponte M, Abadi I
J Clin Immunol. 1987; 7(5):356-64.
PMID: 2958493
DOI: 10.1007/BF00917013.
Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.
GRAY J, Lash A, Bakke A, Kitridou R, Horwitz D
Clin Exp Immunol. 1987; 67(3):556-64.
PMID: 2955974
PMC: 1542635.
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study.
Balsari A, Marolda R, Gambacorti-Passerini C, Sciorelli G, Tona G, Cosulich E
Cancer Immunol Immunother. 1986; 21(2):148-55.
PMID: 2936447
PMC: 11038247.
DOI: 10.1007/BF00199863.
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.
Bussolino F, Breviario F, Tetta C, Aglietta M, Mantovani A, Dejana E
J Clin Invest. 1986; 77(6):2027-33.
PMID: 2872233
PMC: 370564.
DOI: 10.1172/JCI112532.
Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.
Brookes R, Kew M, Rabson A
Cancer Immunol Immunother. 1987; 25(2):149-52.
PMID: 2822243
PMC: 11041111.
DOI: 10.1007/BF00199956.